NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
September 25, 2012
NeuroGeneration recruits top neuroscientiest to lead new Division in La Jolla....PRESS RELEASE
December 13, 2010
NeuroGeneration invited speaker at Shanghai's International Regenerative Medicine and Stem Cells..PRESS RELEASE
June 17, 2010
NeuroGeneration's Paper Highlighed at International Parkinson's Society Meeting ....read more: PRESS RELEASE
NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.